Analysis of primary data from TCGA identified 100 breast and ovarian tumors with germline BRCA1 (n = 55) and BRCA2 (n = 45) mutations (Supplementary Fig. 1, Supplementary Data 1, Supplementary Table 1). This evidence concerns the gene BRCA2 and ovarian neoplasm.